2023-07-18
We obtained a license for manufacturing and marketing of first-class medical devices.
On May 26, 2023, we obtained a license for manufacturing and marketing of first-class medical devices. All employees will continue to make efforts to commercialize the developed products.
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
2023-11-15
Kiyotaka Iwasaki will be on stage as a speaker at the 1st Japanese Knee Society Conference, held on December 8th, 2023
2023-10-12
CTBE will attend JHVS 2023 in Yokohama